1. Home
  2. IRON vs DRH Comparison

IRON vs DRH Comparison

Compare IRON & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$67.14

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

HOLD

Current Price

$10.66

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
DRH
Founded
2017
2004
Country
United States
United States
Employees
N/A
35
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
DRH
Price
$67.14
$10.66
Analyst Decision
Strong Buy
Buy
Analyst Count
11
10
Target Price
$103.18
$10.38
AVG Volume (30 Days)
265.6K
1.7M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
3.51%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.44
Revenue Next Year
$283.52
$2.42
P/E Ratio
N/A
$38.41
Revenue Growth
N/A
N/A
52 Week Low
$40.00
$7.31
52 Week High
$99.50
$10.68

Technical Indicators

Market Signals
Indicator
IRON
DRH
Relative Strength Index (RSI) 50.89 64.29
Support Level $57.79 $9.10
Resistance Level $69.36 $10.65
Average True Range (ATR) 2.62 0.25
MACD -0.37 0.00
Stochastic Oscillator 32.16 86.36

Price Performance

Historical Comparison
IRON
DRH

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The company operates in one reportable segment: The hotel ownership segment, which is comprised of upper upscale and luxury chain scale hotels that offer hotel rooms, food and beverage and other ancillary guest services.

Share on Social Networks: